These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Yamaguchi T; Mori E; Minematsu K; Nakagawara J; Hashi K; Saito I; Shinohara Y; Stroke; 2006 Jul; 37(7):1810-5. PubMed ID: 16763187 [TBL] [Abstract][Full Text] [Related]
47. Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Chalela JA; Kasner SE; Jauch EC; Pancioli AM Stroke; 1999 Nov; 30(11):2366-8. PubMed ID: 10548672 [TBL] [Abstract][Full Text] [Related]
48. Transition of European Cooperative Acute Stroke Study III results to clinical practice: ninety-day outcomes in a US cohort. Cronin CA; Langenberg P; Dutta TM; Kittner SJ Stroke; 2013 Dec; 44(12):3544-6. PubMed ID: 24092551 [TBL] [Abstract][Full Text] [Related]
49. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours. Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683 [TBL] [Abstract][Full Text] [Related]
50. Comparison of tissue plasminogen activator administration management between Telestroke Network hospitals and academic stroke centers: the Telemedical Pilot Project for Integrative Stroke Care in Bavaria/Germany. Audebert HJ; Kukla C; Vatankhah B; Gotzler B; Schenkel J; Hofer S; Fürst A; Haberl RL Stroke; 2006 Jul; 37(7):1822-7. PubMed ID: 16763192 [TBL] [Abstract][Full Text] [Related]
51. Role of tissue plasminogen activator in acute ischemic stroke. Hatcher MA; Starr JA Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027 [TBL] [Abstract][Full Text] [Related]
52. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study. García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450 [TBL] [Abstract][Full Text] [Related]
53. An open, multicenter trial of recombinant tissue plasminogen activator in acute stroke. A progress report. The rt-PA Acute Stroke Study Group. del Zoppo GJ Stroke; 1990 Dec; 21(12 Suppl):IV174-5. PubMed ID: 2124386 [TBL] [Abstract][Full Text] [Related]
54. Tissue plasminogen activator for acute ischemic stroke in clinical practice: a meta-analysis of safety data. Graham GD Stroke; 2003 Dec; 34(12):2847-50. PubMed ID: 14605319 [TBL] [Abstract][Full Text] [Related]
55. Thrombolytic treatment of acute ischemic stroke. Meschia JF; Miller DA; Brott TG Mayo Clin Proc; 2002 Jun; 77(6):542-51. PubMed ID: 12059124 [TBL] [Abstract][Full Text] [Related]
56. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World. Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371 [TBL] [Abstract][Full Text] [Related]
58. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients. Grotta J N Engl J Med; 1997 Oct; 337(18):1310-3. PubMed ID: 9345085 [No Abstract] [Full Text] [Related]
59. [Intravenous thrombolytic treatment in acute ischemic stroke: initial results in the Complejo Hospitalario Universitario de Albacete]. García-García J; Gracia-Gil J; Sopelana-Garay D; Ayo-Martín O; Vadillo-Bermejo A; Touza B; Peñalver-Pardines C; Zorita MD; Segura T Rev Neurol; 2008 Jan 1-15; 46(1):7-12. PubMed ID: 18214820 [TBL] [Abstract][Full Text] [Related]